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Abstract  
Objective: There is no established minimum clinically important difference (MCID) for the 
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) index and total 
scale scores. This study aimed to estimate the MCID for the RBANS index scores and total 
scale score.  
Method: Participants included 1,856 ethnic Chinese, older adults. Distribution and anchor-
based methods were used to estimate values for the MCID. Distribution-based estimates were 
calculated as the standard error of measurement (SEM) and 0.5 standard deviations (SD). For 
anchor-based estimates we compared RBANS scores between the clinical dementia rating 
(CDR) scale no dementia and very mild dementia groups and between the clinical assessment 
of dementia (CAD) cognitively normal and mild cognitive impairment groups using regression 
models adjusting for demographic characteristics.  
Results: Estimates from the CDR anchor were 7.79, 8.63, 10.74, 9.74, 5.61 and 3.77 for the 
total scale score, language, immediate memory, delayed memory, visuospatial/constructional 
and the attention index, respectively. Estimates from the distribution-based methods were 
similar to the estimates based on the CDR, except for the language and attention indexes. 
Estimates from the clinical assessment of dementia (CAD) anchor were larger.  
Conclusions: We estimated the MCID for the total scale score, language, immediate memory, 
delayed memory, visuospatial/constructional and attention indexes of the RBANS as 8, 9, 10, 
10, 6 and 4 points, respectively. These estimates are best suited to discriminate between patient 
groups, in for example, a clinical trial setting. Further research is needed using longitudinal 
data to assess their applicability to assess within patient differences. 
Keywords: Neuropsychological test, Elderly/Geriatrics/Ageing, Mild cognitive impairment, 
minimum clinically important difference, Chinese  
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Introduction 
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was 
designed to identify and characterize abnormal cognitive decline in older adults (Randolph, 
1998). The RBANS has also been shown to be sensitive to detecting impairments in patients 
with mild cognitive impairment (MCI) (Badenes, Casas, Cejudo & Aguilar, 2008; Mahncke et 
al., 2006; Kotani et al., 2006). The battery is comprised of 12 subtests that assess the domains 
of immediate and delayed memory, language, attention and visuospatial/construction 
(Randolph, 1998). The concise structure of the RBANS and its ease of use make it an attractive 
tool for older patients compared to lengthier and more difficult neuropsychological assessments 
(Randolph, Tierney, Mohr & Chase, 1998). These characteristics also make it a useful battery 
for clinicians evaluating elderly patients with abnormal cognitive decline. However, to date 
there is no direct clinical interpretation for the numerical scores derived from the RBANS that 
can be applied objectively and systematically in either a clinical trial or clinical practice setting. 
Clinical trials that compare two groups of patients receiving different treatments or 
interventions conventionally report their results in terms of statistical significance, which is a 
mathematical way of expressing the likelihood that an observed difference is unlikely to have 
been caused by chance. However, statistical significance does not necessarily equate to clinical 
significance, which refers to the practical importance of the observed difference. Clinical 
significance also plays a role in interpreting results in clinical practice with regards to 
instruments such as the RBANS, which are based on summary scores across multiple 
dimensions.  Interpreting results from such instruments can lack objectivity if clinicians must 
rely on personal experience with individual patients and populations (Hermes, Sokoloff, Stroup 
& Rosenheck, 2012). The minimum clinically important difference (MCID) has been proposed 
as a more objective way of establishing clinical relevance to changes in standardized instrument 
scores such as the RBANS and can be used in assessing the effectiveness of a treatment. Guyatt, 
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Walter and Norman (1985) highlighted the importance of establishing the MCID of an 
instrument in order to assess the instrument’s responsiveness to change. Since then there have 
been several proposed definitions of the MCID. The most quoted definition comes from 
Jaeschke, Singer and Norman (1989) who described it as “the smallest difference … which 
patients perceive as beneficial and which would mandate, in the absence of troublesome side 
effects and excessive cost, a change in the patient’s management.” MCID depends on patient 
populations, therefore there are often a range of estimates for a specific instrument (Revicki, 
Hays, Cella & Sloan, 2008). 
A number of methods have been established over recent years to estimate the MCID. Lydick 
and Epstein (1993) provided an important taxonomy for these methods: anchor-based methods 
and distribution-based methods. Anchor-based methods compare the standardized instrument 
scores to some external criterion, which may be clinician or patient rated such as the Clinical 
Dementia Rating (CDR) scale (Hughes, Berg, Danziger, Coben & Martin, 19820). 
Distribution-based methods estimate the MCID based on some measure of variability of the 
observed scores, such as the standard error of measurement (SEM), standard deviation (SD) or 
the effect size (Copay, Subach, Glassman, Polly & Schuler, 2007). Copay et al. (2007) and 
King (2011) have both reviewed and summarized the most popular methods within these 
categories in use today. However, there is no clear consensus on the best estimation method 
and current best practice advocates the use of multiple methods to estimate the MCID (Guyatt, 
Osoba, Wu, Wyrwich & Geoffrey, 2002; Revicki et al., 2008). Revicki et al. (2008) advised to 
base the MCID, “primarily on relevant patient-based and clinical anchors, with clinical trial 
experiences to further inform understanding”, and that distribution-based methods should be 
used to “support and help interpret estimates from anchor-based approaches”, or when no 
anchor-based estimates are available. This in turn was recommended by the US FDA in their 
guidance for industry on patient reported outcomes (Food and Drug Administration, 2009) and 
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the statement of the Initiative on Methods, Measurement and Pain Assessment in Clinical Trials 
(IMMPACT) (Dworkin et al., 2008). 
The MCID has already been established for a number of instruments based on summary scores 
across multiple dimensions similar to the RBANS. For example, Kohn, Sidovar, Kaur, Zhu & 
Coleman (2014) established a range of MCIDs using distribution based methods for the 
EuroQol 5-dimension (EQ-5D) health status index in persons with multiple sclerosis; and Y.T. 
Cheung et al., (2014) used both anchor and distribution based techniques to establish the MCID 
for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast 
cancer patients.  In a study that compared the English original versus the Chinese translation 
of a quality of life questionnaire, a distribution based approach was used to define a MCID as 
0.25 SD (Cheung et al., 2004). Having controlled for potential confounders, two physical well-
being item scores were found statistically significantly different between respondents to the 
English and Chinese versions: one of them had a mean difference of 0.41 SD whereas the other 
only differed by 0.16 SD. The former was concluded as clinically significantly different 
between the two language versions but that latter was not. 
The Singapore Longitudinal Ageing Study (SLAS- II) is an ongoing population based study of 
ageing, community dwelling adults in Singapore. The aim of this study was to estimate the 
MCID of the RBANS for each index score and the total scale score using both anchor and 
distributive-based techniques. As only cross-sectional data was available for the analysis, 
MCID estimates were based on between patient differences; estimates based on change over 
time within patient were not possible.  
Methods 
Sample 
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The design and methods of SLAS-II have been described previously (Lim, Collinson, Feng & 
Ng, 2010). In summary, trained research nurses conducted recruitment via door-to-door visits 
between March 2008 and October 2013. Consenting participants made an appointment to visit 
the research center at a later date to receive a battery of neuropsychological and clinical 
assessments, including the RBANS. Those with a Mini-Mental State Examination (MMSE) 
score < 26 on the locally validated Singaporean, translated, and modified version (Ng, Niti, 
Chiam & Kua, 2007) underwent further clinical assessments, including the CDR scale (Hughes 
et al., 1982), clinical and laboratory tests and a final panel review for diagnosis of Alzheimer’s 
Disease (AD) or other dementias (Nyunt et al., 2013). Feng, Chong, Lim and Ng (2012) have 
previously shown that 26 is the optimal cut-off on the local MMSE version for detecting early 
cognitive impairment. The small number of non-Chinese participants (Malays, Indians, and 
others) recruited into the SLAS-II study rendered inferences regarding ethnicity meaningless, 
hence they were excluded from this analysis. The study was approved by the National 
University of Singapore (NUS) Institutional Review Board (IRB).  
Measures 
The RBANS (Form A) was administered to the participants once in the language–dialect 
(English, Mandarin, Hokkien, Teochew or Cantonese) according to their dominant or habitual 
preference, by trained research nurses who were fluent in that particular language–dialect 
(Collinson, Fang, Lim, Feng & Ng, 2014). Mandarin is the official Chinese language used in 
Singapore and China. Hokkien, Teochew and Cantonese are dialects commonly used in 
Singapore and southern China. The translation procedure by a committee of trained 
multilingual research psychologists has previously been described (Collinson et al., 2014) and 
the equivalence of these translated test scores to the original English version has been 
investigated and reported (Phillips et al., 2015). Individual test performance was scored 
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according to standardized instructions (Randolph, 1998), except for the figure copy and figure 
recall subtests, which were scored according to the widely accepted, modified criteria, 
suggested by Duff et al. (2003) to give the 12 raw subtest scores. These 12 raw subtest scores 
were then standardized across age categories (54 to 59 years old, 60 to 64 years old, 65 to 69 
years old, 70 to 74 years old and 75 years and above) using the means and standard deviations 
produced by Collinson et al. (2014) and then transformed to scores with a mean of 100 and 
standard deviation of 15.  Collinson et al. (2014) also scored the individual test performance as 
per the standardized instructions proposed by Randolph (1998), with the exception of the figure 
copy and figure recall subtest which used the modified criteria proposed by Duff et al. (2003). 
Population specific norms were used as opposed to the standard US norms due to evidenced 
differences in neuropsychological performance between Asian and Caucasian populations 
(Boone, Victor, Wen, Razani & Ponto´n, 2007; Fuji, 2010; Hedden et al., 2002; Shan, Chen, 
Lee & Su, 2008). The five index scores (immediate memory, delayed memory, language, 
attention and visuospatial/construction) were then calculated by summing the transformed 
scores of the subtests that contribute to that specific index and taking the mean. The total scale 
score was derived by taking the mean of the sum of the five index scores. Higher scores on the 
five index scores and the total scale score indicated better performance. 
The CDR is a semi-structured interview used to stage the severity of dementia covering the 
following domains: memory, orientation, judgement and problem solving, community affairs, 
home and hobbies, and personal care (Hughes et al., 1982). It was originally developed for use 
in people with Alzheimer’s but can be used to stage dementia in other illnesses. A translation 
into Chinese has previously been reported with details of cultural modifications (Li, Ng, Kua 
& Ko, 2005). It is a five point scale where: 0 = no cognitive impairment; 0.5 = very mild 
dementia; 1 = mild dementia; 2 = moderate dementia; 3 = severe dementia. The CDR was 
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assumed to be 0 for those who had MMSE>=26, which was the study’s cut-off for including 
the participants in further clinical assessments for dementia. 
A panel comprised of 2 geriatricians, 1 neuropsychiatrist, 1 psychiatric epidemiologist and 3 
clinical assessors reviewed the CDR classification, the clinical history, physical examination 
and laboratory investigations results, and the brain MRI scans to make a unanimous diagnosis 
of mild cognitive impairment (MCI) or dementia according to published criteria (Nyunt et al., 
20130; Petersen et al., 1999). A diagnosis of cognitively normal was assumed for those with 
MMSE ≥ 26. This diagnosis is referred to as the clinical assessment of dementia (CAD) 
classification. 
Statistical analysis 
Participants were included in the analysis if they had completed all RBANS subtests and 
reported their age. Only RBANS assessments administered by a research nurse who conducted 
at least 10 RBANS interviews in both English and Chinese (Mandarin and/or dialects) were 
included.  The latter inclusion criterion was intended to allow statistical control for prevention 
of interviewer effect that may confound the CDR (or CAD) comparison.   
Demographic and baseline characteristics including gender, education level, language, CDR 
and CAD classification were summarized by counts and percentages; and continuous variables 
such as age, Geriatric Depression Scales (GDS), MMSE and physical activity scores were 
summarized by means and standard deviations (SD). The RBANS index scores and the total 
scale score were summarized by means and SDs across CDR classification and the CAD 
classification. 
We have previously demonstrated that the different language-dialect versions of RBANS 
showed practically equivalent scores, with two exceptions: the attention index of the English 
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language version was not equivalent to any of the Chinese language versions (Mandarin, 
Hokkien, Teochew or Cantonese), and the visuospatial/constructional index of the English 
language version was not equivalent to the Hokkien or Teochew language versions (Phillips et 
al., 2015). Therefore, the RBANS attention index was summarized across each language and 
the visuospatial/constructional index was summarized by English, Mandarin and Cantonese 
combined and Hokkien and Teochew individually.  
Distribution-based approaches. Distribution-based methods estimate the MCID based on some 
measure of variability of the observed scores (Copay et al., 2007). In this study we examined 
the following: 
(1) MCID calculated as the standard error of measurement (SEM). This is a measure of the 
variation in scores due to the unreliability in the scale used. A smaller difference or change in 
score than the SEM is likely to be due to measurement error. It was calculated as the standard 
deviation (SD) of the measure multiplied by the square root of 1 minus the measure’s reliability 
coefficient: 
SEM = 𝑆𝐷 × √1 − 𝑟  
where r is the reliability as measured by Cronbach’s alpha for this analysis. It has been noted 
that the value of 1 SEM corresponded to the MCID value when defined with the classic anchor-
based method (Wyrwich, Nienaber,  Tierney & Wolinsky, 1999; Wyrwich, Tierney & 
Wolinsky, 1999). Others have suggested different values. For example, Ware, Kosinski and 
Keller (1994) used 2 SEM. However, 1 SEM has become the generally accepted value to 
present as the MCID.  
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(2) MCID calculated using the standard deviation (SD) of the scores. SD is the variation among 
a group of scores. Norman, Sloan and Wyrwich (2003) found that the 0.5 SD corresponded to 
the MCID across a variety of studies.  
Due to the non-equivalence of language versions previously discussed, we repeated each of the 
above distributional-based methods for each language individually for the attention index and 
the English, Mandarin and Cantonese combined and the Teochew and Hokkien individually 
for the visuospatial/constructional index. 
Anchor-based approaches. We compared the RBANS index scores and total scale score of 
participants between the CDR no dementia group and the CDR very mild dementia group. 
Additionally, we compared the RBANS scores between the CAD cognitively normal diagnosis 
group and the CAD MCI diagnosis group.  Regression models for each of the five RBANS 
index scores and the RBANS total scale score were fitted to compare scores between no 
dementia (CDR=0) and very mild dementia (CDR=0.5) to establish each indexes’ (or total scale 
score) MCID. To remove potential confounding by differences in demographic characteristics 
(age, gender, and education level) covariates were included. Furthermore, to prevent 
confounding by interviewer effects, a mixed model approach was used to include the research 
nurse as a random-effect (Y. B. Cheung, 2014).     
Due to the non-equivalence of language versions, we refitted the above model with an 
additional covariate for language version for the attention index and the 
visuospatial/constructional index. Language was included as a categorical variable with values 
presenting English, Mandarin, Hokkien, Teochew and Cantonese for the attention index; and 
values presenting English, Mandarin, Cantonese combined, and Hokkien and Teochew 
individually for the visuospatial/constructional index. 
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We repeated the above to compare the RBANS total scale score and index scores between those 
classed as cognitively normal and those as MCI according to the CAD classification. 
All estimates of the MCID are given in the metrics of mean 100 and SD 15. 
Results 
Descriptive Summary 
The sample consisted of 1,856 participants with complete RBANS data. The mean age of 
participants was 66.28 years (SD 7.54), they were predominantly female (62.77% compared to 
37.23% males), with a fifth having received no formal education (18.48%) and just over two-
thirds (70.96%) receiving 10 years or less. Cantonese was the most common language 
preference (26.24%), closely followed by Mandarin (25.38%), English (21.66%), Hokkien 
(20.26%) and Teochew (6.47%).   Mean GDS was in the normal range (0.72 SD 1.48). 
CDR classification was available for 1,802 (97.09%) participants, the majority of which were 
classified as having no dementia (86.26%), with 9.48% having very mild dementia. There were 
no cases of severe dementia in the sample. CAD classification was available for 1,745 (94.02%) 
participants, with the majority being classified as cognitively normal (89.33%), 3.56% were 
given a diagnosis of MCI and 1.13% were given a dementia diagnosis (Table 1). 
Mean RBANS index scores and the total scale score decreased across all indexes as the CDR 
classification indicated increasing levels of cognitive impairment (Table 2). Mean RBANS 
index scores and the total scale score decreased across all indexes as the CAD classification 
moved from cognitively normal, to mildly cognitively impaired through to dementia (Table 3).  
Minimum Clinically Important Difference 
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Distribution-based approach. The threshold according to the SEM approach for the total scale 
score was 5.26 and approximately 10 for each index; the exception was the threshold for the 
language index which was 14.84. The threshold estimated from the SD was approximately the 
same as the estimate from the SEM for the total scale score, whereas the estimates for the other 
indexes were at least one point smaller than the estimates from the SEM (Table 4). 
Anchor-based approach. The MCID estimates with the CDR classification (no dementia vs. 
very mild dementia) were 7.79, 10.74, 8.63 and 9.74 for the total scale score, immediate 
memory index, language index and delayed memory index, respectively. The estimates for the 
visuospatial/constructional and attention indexes with language adjustment were somewhat 
smaller at 5.61 and 3.77, respectively (Table 5). 
The MCID estimates with the CAD classification (cognitively normal compared to MCI) were 
9.98, 12.16, 14.30 and 11.14, for the total scale score, immediate memory index, language 
index and delayed memory index, respectively.  Again the estimates for the 
visuospatial/constructional and attention indexes were somewhat smaller at 6.88 and 4.58, 
respectively (Table 6). The estimates with the CAD classification were approximately no more 
than two points larger than the CDR estimates.  The exception being the language index, which 
was over 5 points larger. 
Overall. Figure 1 presents the estimates for the MCID for the immediate memory index, 
language index, delayed memory index and the total scale score according to each 
distributional and anchor-based approach. The anchor-based method using the CAD 
classification tended to give the largest estimate for the MCID and the distributional-based 
method using the SD gave the smallest estimate. The anchor-based method using the CDR 
classification and the SEM tended to be within 2 points of each other. Again, the exception to 
this was the language index where the SEM and anchor-based approach using the CAD gave 
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the largest scores and the anchor-based estimate using the CDR and the distributional estimate 
using the SD gave the smallest. Estimates for each index tended to span a 5 point width across 
estimates. 
Figures 2 and 3 present the estimates for the MCID for the indexes that did not achieve 
language equivalence, the visuospatial/constructional index and the attention index. The SEM 
approach produced the largest estimate for each index. The anchor-based approach using the 
CDR produced the smallest with the other two estimates (SD and anchor-based approach with 
CAD) falling within two points of it. 
Discussion  
The RBANS is a useful battery to evaluate elderly patients with abnormal cognitive decline in 
both clinical trials and clinical practice. However, to date there is no objective clinical 
interpretation for the numerical scores, therefore understanding the MCID in this assessment 
is critical in assessing the effectiveness of a treatment or clinical significance/patient relevance. 
The aim of this study was to estimate the MCID of the RBANS for each index score and the 
total scale score, scored according to the widely accepted, modified criteria, suggested by Duff 
et al. (2003). We used both anchor-based and distribution-based analytical techniques to obtain 
the estimates, which could be used to compare patient groups, in for example, a randomized 
clinical trial setting. The study used data from a large cohort, the SLAS-II population based 
study of ageing, community dwelling adults in Singapore.  
All estimates of the MCID are given in the metrics of mean 100 and SD 15. For the RBANS 
indexes that previously demonstrated equivalence in scores across language versions, 
immediate memory, language and delayed memory, the anchor-based method using the CDR 
gave estimates for the MCID of 10.74, 8.63 and 9.74, respectively. The estimate for the MCID 
for the total scale score was slightly smaller at 7.79. The thresholds estimated from the SEM 
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calculation yielded similar values. The exception to this was for the language index where the 
SEM estimate was more in line with the CAD anchor estimate. Not unexpectedly the estimates 
from the CAD anchor gave marginally larger thresholds. This was expected since the CDR 
anchor examined change between cognitively normal and very mild cognitive impairment, 
whereas the CAD minimum threshold was between cognitively normal and MCI, which by 
definition describes a greater level of cognitive impairment and a greater decrease in RBANS 
scores would be expected in this group. 
The two exceptions to the equivalence in scores across language versions were the 
visuospatial/constructional index and the attention index.  For these indexes we found that the 
anchor-based method using the CDR gave estimates of 5.61 and 3.77 respectively, with the 
CAD estimates only marginally larger but the SEM calculation yielded estimates of 
approximately 10 points. 
The estimates from the distribution-based methods were similar for the total scale score (5.26 
for the SEM method and 5.39 for the 0.5*SD) and the delayed memory index (9.34 for the 
SEM method and 8.13 for the 0.5*SD). Mathematically, when the reliability measure for the 
index is 0.75 (a moderate level of reliability), these two methods exactly agree.  Cronbach’s 
alpha, the measure of reliability used in this study, was 0.76 and 0.67 for total scale and delayed 
memory index, respectively. Hence, the similarity between the MCID estimates from the two 
methods. The largest differences in estimates were for the language index and attention index, 
which had smaller Cronbach’s alpha values (0.31 and 0.21, respectively). These weaker 
reliability values are in line with other studies that have looked at the reliability of the RBANS 
indexes (McKay, Casey, Wertheimer & Fichenberg, 2007; Cheng et al., 2001).  
Not unexpectedly, there was variation in the MCID estimates across indexes. For example, the 
estimates from the SEM method ranged from 5.26 to 14.84.  The weaker reliability values for 
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the language and attention indexes would lead to larger differences being required to convince 
users that any change was not due to insufficient reliability, hence the larger MCID estimates 
for these indexes compared to the indexes with stronger reliability values. The MCID estimates 
produced by the anchor based estimates ranged from 3.77 to 10.74. These estimates were 
obtained by comparing two groups, those with normal cognition and those with very mild 
dementia, as defined by the CDR. In this community dwelling, Chinese sample we expected 
that Alzheimer’s Disease would be the dominant subtype of pathology in the early stage 
dementia patients. Biologically there is more impairment in memory in Alzheimer’s patients 
than other dementia types, hence greater MCID estimates were obtained for memory indexes 
than other indexes using this estimation method.   
No study has previously examined the MCID for the RBANS. Patton et al. found a 3 point 
decrease in RBANS total score over a 1 year period in a group of cognitively intact, community 
dwelling, older adults (mean age 72.5 years) and Lee et al. found a 1.2 point increase and a 3.5 
point decrease in RBANS total scale score over an 8 week period in elderly, (mean age 65.1 
and 65.2 years, respectively), cognitively normal, English and Chinese speaking adults, 
respectively (Patton et al., 2005; Lee et al., 2013; Lee et al., 2015). This gives an indication of 
the changes one would expect to see in cognitively intact adults. Therefore, the larger estimates 
we obtained that distinguish between cognitively normal and very mild impairment are in 
keeping with these findings.   
There were several limitations to this study. Firstly, there are many different methods to 
calculate the MCID. As we have shown, anchor-based methods produce different MCIDs 
depending on the external criterion used and the distribution-based methods depend on the 
measure of statistical variability used. Distribution-based methods also fail to account for the 
clinical importance/patient relevance, which is at the very core of MCIDs. However, Revicki 
et al. (2008) recommended that the MCID should be based on relevant anchor-based 
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approaches and this has subsequently been recommended by the US FDA in their guidance for 
industry on patient reported outcomes (Food and Drug Administration, 2009) and the 
IMMPACT statement (Dworkin et al., 2008). Therefore, our conclusions are in line with 
current guidelines. 
Secondly, there was only cross-sectional data available for the analysis, so MCID estimates 
were based on between patient differences; estimates based on within patient differences were 
not possible. Therefore, these estimates would be more suited to discriminate between patient 
groups rather than assessing response to treatment (Kohn et al., 2014). For example, in a 
clinical trial setting where one is trying to determine if a statistically significant difference 
between treatment groups, is large enough to be considered clinically significant.  
For the anchor-based estimates the use of mixed effects models, adjusting for differences in 
characteristics amongst participants and controlling for interviewer effects, would help reduce 
the risk of confounding i.e. a characteristic that may affect the RBANS scores other than the 
CDR (or CAD) classification. However, there may still be the risk of residual confounding 
(Y.B. Cheung, 2014). Also, the anchor-based approaches were limited to the study population 
that was assessed using CDR (97.09%) and diagnosed according to the CAD criteria (94.02%). 
Examination of the demographics found that those with missing CDR and CAD assessments 
were similar in terms of mean age and sex. However, a greater proportion of the non-completers 
had received no education (51.85% for the CDR and 52.73% for the CDR). The non-completers 
also had smaller mean MMSE scores for both the CDR and CAD (22.71 and 22.68, 
respectively).  This raises the issue that our analysis is missing some of the participants with 
mild dementia. The distribution based estimates are concerned with the distribution of the 
RBANS scores, therefore by their very nature they do not account for any differences in 
characteristics amongst the participants. However, the distribution based estimates were similar 
The MCID for the RBANS 
17 
 
to the anchor based estimates based on the CDR, which suggests that in this population it is 
mild dementia not age or education or gender that is the key determinant of RBANS.  
Recruitment was conducted via door-to-door visits and specifically targeted senior activity 
centers, elderly day care centers, and elderly homes across different community neighborhoods 
in Singapore. This was to ensure that the sample population was truly representative of the 
target population, i.e., Singaporean, elderly population. Our sample age ranged from 54 to 94 
years of age, and the sex, education profile of participants closely followed the distribution of 
the Singaporean population aged over 55 years, according to the 2010 Singapore Census.  
However, one must also note that the use of a Singaporean population and use of Singaporean 
population norms for scoring the RBANS likely limits the generalizability, although Singapore 
normative data may have applicability to ethnic Chinese living outside of Asia. 
In conclusion, based on current guidance we estimate the MCID to be 8 points for the RBANS 
total scale score, 9 points for the language index, 10 points for the RBANS immediate memory 
and delayed memory indexes and 6 and 4 points for the RBANS visuospatial/constructional 
and attention indexes, respectively. We recommend that the MCIDs estimated here are best 
suited to discriminate between patient groups, in for example, a clinical trial setting. At present, 
clinicians can use RBANS scores in clinical practice along with their judgment based on their 
clinical experiences. Further research is needed using longitudinal data to assess their 
applicability to assess within patient differences.  
  
The MCID for the RBANS 
18 
 
Acknowledgments  
 
 
 
 
 
  
The MCID for the RBANS 
19 
 
References 
Badenes, G.D., Casas, H.L., Cejudo, B.J.C., & Aguilar, B.M. (2008). Evaluation of the capacity 
to drive in patients diagnosed of mild cognitive impairment and dementia. (Article in Spanish). 
Neurologia, 23(9), 575-582. 
Boone, K.B., Victor, T.L., Wen, J., Razani, J., & Ponto´n, M. (2007). The association between 
neuropsychological scores and ethnicity, language, and acculturation variables in a large 
patient population. Archives of Clinical Neuropsychology, 22(3), 355-365. 
doi:10.1016/j.acn.2007.01.010. 
Cheng, Y., Wu, W., Wang, J., Feng, W., Wu X., & Li, C. (2001). Reliability and validity of 
the Repeatable Battery for the Assessment of Neuropsychological Status in community 
dwelling elderly. Archives of Medical Science, 7(5), 850-857. doi:10.5114/aoms.2011.25561. 
Cheung, Y.B., Thumboo, J., Goh, C., Khoo, K.S., Che, W., & Wee, J. (2004). The equivalence 
and difference between the English and Chinese versions of two major, cancer-specific, health-
related quality-of-life questionnaires. Cancer, 101(12), 2874-2880. doi: 10.1002/cncr.20681. 
Cheung, Y.B. (2014). Statistical analysis of Human Growth and Development. Chapman & 
Hall/CRC Biostatistics Series. 
Cheung, Y.T., Foo, Y.L., Shwe, M., Tan, Y.P., Fan, G., Yong, W.S., … Chan, A. (2014). 
Minimal clinically important difference (MCID) for the functional assessment of cancer 
therarpy: Cognitive function (FACT-Cog) in breast cancer patients. Journal of Clinical 
Epidemiology, 67, 811-820. doi: 10.1016/j.jclinepi.2013.12.011. 
The MCID for the RBANS 
20 
 
Collinson, S.L., Fang, S.H., Lim, M.L., Feng, L., & Ng, T.P. (2014). Normative data for the 
Repeatable Battery for the Assessment of Neuropsychological Status in elderly Chinese. 
Archives of Clinical Neuropsychology, 29(5), 442-455. doi:10.1093/arclin/acu023. 
Copay, A.G., Subach, B.R., Glassman, S.D., Polly, D.W., & Schuler, T.C. (2007). 
Understanding the minimum clinically important difference: a review of concepts and methods. 
The Spine Journal, 7, 541-546. doi:10.1016/j.spinee.2007.01.008. 
Duff, K., Patton, D., Schoenberg, M.R., Mold, J., Scott, J.G., & Adams, R.L. (2003). Age and 
education-corrected independent normative data for the RBANS in a community dwelling 
elderly sample. The Clinical Neuropsychologist, 17(3), 351-366. 
doi:10.1076/clin.17.3.351.18082. 
Duff, K., Schoenberg M.R., Patton, D., Paulsen, J.S., Bayless, J.D., Mold, J., … Adams, R.L. 
(2005). Regression-based formulas for predicting change in RBANS subtests with older adults. 
Archives of Clinical Neuropsychology, 20, 281, 290. doi:10.1016/j.acn.2004.07.007. 
Dworkin, R.H., Turk, D.C., Wyrwich, K.W., Beaton, D., Cleeland, C.S., Farrar, J.T., … 
Zavisic, S.  (2008). Interpreting the clinical importance of treatment outcomes in chronic pain 
clinical trials: IMMPACT recommendations. The Journal of Pain, 9(2), 105-121. 
doi:10.1016/j.jpain.2007.09.005. 
Feng, L., Chong, M.S., Lim, W.S., & Ng, T.P. (2012) The Modified Mini-Mental State 
Examination test: normative data for Singapore Chinese older adults and its performance in 
detecting early cognitive impairment.  Singapore Medical Journal, 53(7), 458-462. 
Food and Drug Administration. (2009). Guidance for industry. Patient reported outcome 
measures: use in medical product development to support labelling claims. Federal Register 
74(235), 65132-65133. 
The MCID for the RBANS 
21 
 
Fuji, D.E.M. (2010). The neuropsychology of Asian-Americans. London: Psychology Press. 
Guyatt, G., Walter, S., & Norman, G. (1985). Measuring change over time: assessing the 
usefulness of evaluative instruments. Journal of Chronic Diseases, 40(2), 171-178. 
Guyatt, G.H., Osoba, D., Wu, A.W., Wyrwich, K.W., & Geoffrey, R. (2002). Clinical 
Significance Consensus Meeting Group, Methods to Explain the Clinical Significance of 
Health Status Measures. Mayo Clinical Proceedings, 77 (4), 371-383. 
http://dx.doi.org/10.4065/77.4.371. 
Hedden, T., Park, D.C., Nisbett, R., Ji, L.J., Jing, Q. & Jiao, S. (2002). Cultural variation in 
verbal versus spatial neuropsychological function across life span. Neuropsychology, 16(1), 
65-73. doi:10.1037//0894-4105.16.1.65. 
Hermes, E.D.A., Sokoloff, D., Stroup, T., & Rosenheck, R.A. (2012). Minimum clinically 
important difference in the positive and negative syndrome scale with data from the clinical 
antipsychotic trials of intervention effectiveness (CATIE). Journal of Clinical Psychiatry, 
73(4), 526-532. doi:10.4088/JCP.11m07162. 
Hughes, C.P., Berg, L., Danziger, W.L. Coben, L.A., & Martin, R.L. (1982). A new clinical 
scale for the staging of dementia. British Journal of Psychiatry, 140, 566-572. 
doi:10.1192/bjp.140.6.566. 
Jaeschke, R., Singer, J., & Guyatt, G.H. (1989). Measurement of health status: ascertaining the 
minimal clinically important difference. Controlled Clinical Trials, 10 (4), 407-415. 
King, A.T. (2011). A point of minimal important difference (MID): a critique of terminology 
and methods. Expert Review of Pharmacoeconomics and Outcomes Research, 11(2), 171-
184. doi: 10.1586/erp.11.9. 
The MCID for the RBANS 
22 
 
Kohn, C.G., Sidovar, M.F., Kaur, K., Zhu, Y. & Coleman, C.I. (2014). Estimating a minimal 
clinically important difference for the EuroQoL 5-dimension health status index in persons 
with multiple sclerosis. Health and Quality of Life Outcomes, 12(66). doi:10.1186/1477-7525-
12-66. 
Kotani, S., Sakaguchi, E., Warashina, S., Matsukawa, N., Ishikura, Y., Kiso, Y., … 
Yamashima, T. (2006). Dietary supplementation of arachidonic and docosahexaenoic acids 
improves cognitive dysfunction. Neuroscience Research, 56, 159-164. 
doi:10.1016/j.neures.2006.06.010. 
Lee, T.S., Goh, S.J.A., Quek, S.Y., Phillips, R., Guan, C., Cheung, Y.B., … Krishnan, K.R.R. 
(2013) A Brain-Computer Interface Based Cognitive Training System for Healthy Elderly: A 
Randomized Control Pilot Study for Usability and Preliminary Efficacy. PLOS ONE, 8(11), 
e79419. doi:10.1371/journal.pone.0079419. 
Lee, T.S., Quek, S.Y., Goh, S.J.A., Phillips, R., Guan, C., Cheung, Y.B., … Krishnan, K.R.R. 
(2015). A pilot randomized controlled trial using EEG-based brain-computer interface training 
for a Chinese-speaking group of healthy elderly. Clinical Interventions in Aging, 10, 217-227. 
doi: 10.2147/CIA.S73955. 
Li, M., Ng, T.P., Kua, E.H., & Ko, S.M. (2005). Brief informant screening test for Mild 
Cognitive Impairment and early Alzheimer’s Disease. Dementia and Geriatric Cognitive 
Disorders, 21, 391-402. doi:10.1159/000092808. 
Lim, M.L., Collinson, S.L., Feng, L., & Ng, T.P. (2010). Cross-cultural application of the 
Repeatable Battery for the assessment of Neuropsychological Status (RBANS): Performances 
of elderly Chinese Singaporeans. The Clinical Neuropsychologist, 24(5), 811-826. 
doi:10.1080/13854046.2010.490789. 
The MCID for the RBANS 
23 
 
Lydick, E., & Epstein, R.S. (1993). Interpretation of quality of life changes. Quality of Life 
Research, 2(3), 221-226. 
Mahncke, H.W., Conner, B.B., Appelman, J., Ahsanuddin, O.N., Hardy, J.L., Wood, R.A., … 
Merzenich, M.M. (2006). Memory enhancement in healthy older adults using a brain plasticity-
based training program: A randomized, controlled study. Proceedings of the National Academy 
of Sciences, 103(33), 12523-12528. doi:10.1073_pnas.0605194103.  
McKay, C., Casey, J.E., Wertheimer, J. & Fichenberg N.L. (2007). Reliability and validity of 
the RBANS in a traumatic brain injured sample. Archives of Clinical Neuropsychology, 22, 91-
98. doi:10.1016/j.acn.2006.11.003. 
Ng, T.P., Niti, M., Chiam, P.C., & Kua, E.H. (2007). Ethnic and educational differences in 
cognitive test performance on Mini-Mental State Examination in Asians. American Journal of 
Geriatric Psychiatry, 15(2), 130-139. doi:10.1097/01.JGP.0000235710.17450.9a. 
Norman, G.R., Sloan, J.A., & Wyrwich, K.W. (2003). Interpretation of changes in health-
related quality of life: the remarkable universality of half a standard deviation. Medical Care, 
41(5), 582–92. 
Nyunt, M.A.Z., Chong, M.S., Lim, W.S., Lee, T.S., Yap, P. & Ng, T.Z. (2013). Reliability and 
validity of the clinical dementia rating for community-living elderly subjects without an 
informant. Dementia and Geriatric Cognitive Disorders Extra, 31(1), 407-416. 
doi:10.1159/000355122. 
Patton, D.E., Duff, K., Schoenberg, M.R., Mold, J., Scott, J.G. & Adams, R.L. (2005). Base 
rates of longitudinal RBANS discrepancies at one and two year intervals in community 
dwelling older adults. The Clinical Neuropsychologist, 19(1), 27-44. 
doi:10.1080/13854040490888477. 
The MCID for the RBANS 
24 
 
Petersen, R.C., Smith, G.E., Waring, S.C., Ivnik, R.J., Tangalos, E.G. & Kokmen, E. (1999). 
Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 
56(3), 303-308. doi:10.1001/archneur.56.3.303. 
Phillips, R., Cheung, Y.B., Collinson, S.L., Lim, M.L., Ling, A., Feng, L. & Ng T.P. (2015). 
The equivalence and difference between the English and Chinese language versions of the 
Repeatable Battery for the Assessment of Neuropsychological Status. The Clinical 
Neuropsychologist. doi: 10.1080/13854046.2015.1034182. 
Randolph, C. (1998). Repeatable Battery for the Assessment of Neuropsychological Status 
(RBANS). San Antonio: Harcourt, TX: The Psychological Corporation. 
Randolph, C., Tierney, M.C., Mohr, E., & Chase, T.N. (1998). The Repeatable Battery for the 
Assessment of Neuropsychological Status (RBANS): Preliminary Clinical Validity. Journal of 
Clinical and Experimental Neuropsychology, 20(3), 310-319. doi:10.1076/jcen.20.3.310.823. 
Revicki, D., Hays, R.D., Cella, D., & Sloan, J. (2008). Recommended methods for determining 
responsiveness and minimally important differences for patient-reported outcomes. Journal of 
Clinical Epidemiology, 61(2), 102-109. doi:10.1016/j.jclinepi.2007.03.012. 
Shan, I.K., Chen, Y.S., Lee, Y.C., & Su, T.P. (2008). Adult normative data of the Wisconsin 
card sorting test in Taiwan. Journal of the Chinese Medical Association, 71(10), 517-522. 
doi:10.1016/S1726-4901(08)70160-6. 
Ware, J.E., Kosinski, M., Keller, S.K. (1994). SF-36 physical and mental health summaries 
scales: a user’s manual. Boston, MA: The Health Institute. 
Wyrwich, K.W., Nienaber, N.A., Tierney, W.M., & Wolinsky, F.D. (1999). Linking clinical 
relevance and statistical significance in evaluating intra-individual changes in health-related 
quality of life. Medical Care, 37(5), 469-478. 
The MCID for the RBANS 
25 
 
Wyrwich, K.W., Tierney, W.M., & Wolinsky, F.D. (1999b).  Further evidence supporting an 
SEM-based criterion for identifying meaningful intra-individual changes in health-related 
quality of life. Journal of Clinical Epidemiology, 52 (9), 861–
73.  http://dx.doi.org/10.1016/S0895-4356(99)00071-2. 
  
The MCID for the RBANS 
26 
 
Table 1: Demographic characteristics (n=1856)   
Variable   n  
Age – years, mean (SD) 1,856 66.28 (7.54) 
GDS score, mean (SD) 1,856 0.72 (1.48) 
MMSE, mean (SD) 1,842 28.11 (2.38) 
Physical activity score, mean (SD) 1,791 8.93 (4.21) 
   
Sex, n (%)   
 Male 691 (37.23) 
 Female 1,165 (62.77) 
Education, n (%)   
 None 343 (18.48) 
 1-3 years 289 (15.57) 
 4-6 years 524 (28.23) 
 7-10 years 504 (27.16) 
 More than 10 years 190 (10.24) 
 Missing 6 (0.32) 
Language, n (%)   
 English 402 (21.66) 
 Mandarin 471 (25.38) 
 Hokkien 376 (20.26) 
 Teochew 120 (6.47) 
 Cantonese 487 (26.24) 
CDR, n (%)   
 0 No dementia 1,601 (86.26) 
 0.5 very mild dementia 176 (9.48) 
 1 mild dementia 23 (1.24) 
 2 moderate dementia 2 (0.11) 
 Missing 54 (2.91) 
CAD, n (%)   
 Cognitively normal 1658 (89.33) 
 MCI 66 (3.56) 
 Dementia 21 (1.13) 
 Missing 111 (5.98) 
SD: standard deviation; GDS: geriatric depression scale; MMSE: mini-mental state 
examination; CDR: clinical dementia rating; CAD: clinical assessment of dementia; 
MCI: mild cognitive impairment. 
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Table 2: Repeatable Battery for the Assessment of Neuropsychological Status total scale score and index scores summarized by the 
Clinical Dementia Rating classification 
 CDR classification 
Overall  0 - No dementia 0.5 - Very mild 
dementia 
1 - Mild dementia 
Variable N Mean SD N Mean SD N Mean SD N Mean SD 
Immediate Memory 1,601 97.84 13.13 176 85.20 14.40 25 73.43 15.85 1,802 96.26 14.08 
Language 1,601 99.22 15.51 176 90.06 28.82 25 77.96 19.64 1,802 98.03 17.68 
Delayed Memory 1,601 96.29 14.72 176 84.65 18.08 25 66.01 23.74 1,802 94.73 15.98 
Total Scale 1,601 98.58 9.53 176 88.68 12.22 25 77.21 11.97 1,802 97.32 10.56 
             
Visuospatial/Constructional 1,601 100.02 12.93 176 90.57 16.88 25 80.27 18.64 1,802 98.82 13.92 
 English/Mandarin/Cantonese 1,211 102.34 11.40 103 95.39 15.04 15 81.65 20.20 1,329 101.56 12.17 
 Hokkien 291 92.79 14.33 59 83.31 17.05 8 79.20 18.70 358 90.92 15.38 
 Teochew 99 92.98 15.70 14 85.72 17.82 2 74.18 8.29 115 91.77 16.13 
             
Attention 1,601 99.55 11.91 176 92.91 11.85 25 88.36 12.54 1,802 98.75 12.13 
 English 370 99.20 13.26 25 88.80 11.74 1 79.72  396 98.49 13.41 
 Mandarin 439 101.57 10.98 23 95.84 13.00 2 88.22 10.10 464 101.23 11.16 
 Hokkien 291 96.51 10.91 59 89.71 12.02 8 83.46 11.06 358 95.10 11.49 
 Teochew 99 97.54 13.92 14 92.93 8.39 2 86.02 10.99 115 96.78 13.42 
 Cantonese 402 100.38 11.23 55 96.97 10.64 12 92.76 14.10 469 99.78 11.33 
SD: standard deviation; CDR: clinical dementia rating scale.  
NOTE: 54 participants did not have a CDR score.  
NOTE: Mild dementia category includes two patients with moderate dementia.  
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Table 3: Repeatable Battery for the Assessment of Neuropsychological Status total scale score and index scores summarized by the Clinical 
Assessment of Dementia classification 
 CAD classification 
Overall 
 Cognitively normal MCI Dementia 
Variable N Mean SD N Mean SD N Mean SD N Mean SD 
Immediate Memory 1,658 97.45 13.39 66 82.75 13.72 21 72.47 12.76 1,745 96.60 13.93 
Language 1,658 99.03 15.75 66 83.69 39.75 21 78.24 21.17 1,745 98.20 17.70 
Delayed Memory 1,658 95.96 14.95 66 82.40 17.17 21 63.82 19.97 1,745 95.06 15.70 
Total Scale 1,658 98.38 9.67 66 85.58 13.32 21 76.20 11.10 1,745 97.63 10.41 
             
Visuospatial/Constructional 1,658 99.94 12.97 66 87.95 17.60 21 77.79 18.54 1,745 99.22 13.65 
 English/Mandarin/Cantonese 1,257 102.23 11.44 32 91.87 17.53 12 78.21 18.77 1,301 101.76 12.02 
 Hokkien 295 92.96 14.20 31 83.87 17.53 7 78.98 21.93 333 91.82 15.02 
 Teochew 106 92.12 16.27 3 88.21 13.92 2 71.08 3.90 111 91.63 16.27 
             
Attention 1,658 99.51 11.93 66 91.09 11.33 21 88.68 14.02 1,745 99.06 12.09 
 English 382 98.91 13.28 8 90.27 12.76 1 79.72  391 98.69 13.33 
 Mandarin 450 101.63 10.96 6 88.73 14.19 2 88.22 10.10 458 101.40 11.10 
 Hokkien 295 96.48 11.18 31 88.37 10.66 7 86.89 17.74 333 95.52 11.57 
 Teochew 106 97.37 13.65 3 91.76 5.20 2 81.07 3.99 111 96.93 13.57 
 Cantonese 425 100.43 11.13 18 96.81 10.52 9 92.86 13.92 452 100.14 11.21 
SD: standard deviation; CAD: clinical assessment of dementia; MCI: mild cognitive impairment. 
NOTE: 111 participants did not have a CAD assessment. 
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Table 4: Distribution-based methods for estimates of the Minimum Clinically Important Difference 
for the Repeatable Battery for the Assessment of Neuropsychological Status total scale score and 
index scores 
    Minimum Clinically Important 
Difference 
RBANS N Mean SD SEM 0.5*SD 
      
Immediate Memory 1,856 95.96 14.19 9.25 7.09 
Language 1,856 97.76 17.92 14.84 8.96 
Delayed Memory 1,856 94.40 16.25 9.34 8.13 
Total Scale 1,856 97.03 10.78 5.26 5.39 
      
Visuospatial/Constructional 1,856 98.56 14.07 9.13 7.03 
 English/Mandarin/Cantonese 1,360 101.35 12.33 8.37 6.17 
 Hokkien 376 90.68 15.51 10.96 7.76 
 Teochew 120 91.63 15.99 10.80 7.99 
      
Attention 1,856 98.47 12.30 10.90 6.15 
 English 402 98.37 13.45 10.34 6.73 
 Mandarin 471 101.10 11.28 9.29 5.64 
 Hokkien 376 94.94 11.64 10.00 5.82 
 Teochew 120 96.24 13.59 9.35 6.80 
 Cantonese 487 99.29 11.71 9.17 5.85 
SEM: standard error of measurement; SD: standard deviation. 
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Table 5: Regression analysis for estimates of the Minimum Clinically Important Difference to 
discriminate between a Clinical Dementia Rating classification of no dementia and a Clinical 
Dementia Rating classification of very mild dementia for the Repeatable Battery for the Assessment 
of Neuropsychological Status total scale score and index scores (n=1769) 
   Minimum Clinically Important 
Difference 
RBANS 
Mean SD 
Adjusted 
Difference a 
95% CI 
Immediate Memory 96.25 14.09 10.74 8.74  12.75 
Language 98.00 17.69 8.63 5.89  11.38 
Delayed Memory 94.73 15.97 9.74 7.37  12.12 
Total Scale 97.32 10.56 7.79 6.32  9.26 
Visuospatial/Constructional b 98.85 13.90 5.61 3.69  7.54 
Attention b 98.74 12.13 3.77 2.05  5.49 
CDR: clinical dementia rating scale; SD: standard deviation; CI: confidence interval. 
a Difference between CDR no dementia vs. CDR very mild dementia, adjusted for age, gender 
and education level. Research nurse included as a random effect. Differences indicate a decrease 
in score (worsening scores) from CDR no dementia to CDR very mild dementia. 
b Additionally adjusted for language. 
NOTE: 54 participants did not have a CDR score and a further 6 participants did not have any 
education data. 
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Table 6: Regression analysis for estimates of the Minimum Clinically Important Difference to 
discriminate between a Clinical Assessment of Dementia classification of cognitively normal and a 
Clinical Assessment of Dementia classification of mild cognitive impairment for the Repeatable 
Battery for the Assessment of Neuropsychological Status total scale score and index scores (n=1740) 
   Minimum Clinically Important 
Difference 
RBANS 
Mean SD 
Adjusted 
Difference a 
95% CI 
Immediate Memory 96.59 13.94 12.16 9.02 15.30 
Language 98.17 17.71 14.30 10.04 18.56 
Delayed Memory 95.06 15.69 11.14 7.48 14.80 
Total Scale 97.62 10.41 9.98 7.70  12.25 
Visuospatial/Constructional b 99.22 13.66 6.88 3.93  9.84 
Attention b 99.05 12.08 4.58 1.90 7.26 
CAD: clinical assessment of dementia; MCI: mild cognitive impairment; SD: standard deviation; 
CI: confidence interval. 
a Difference between CAD cognitively normal vs. CAD MCI, adjusted for age, gender and 
education level. Research nurse included as a random effect. Differences indicate a decrease in 
score (worsening scores) from CAD cognitively normal to CAD MCI. 
b Additionally adjusted for language. 
NOTE: 111 participants did not have CAD assessment and an additional 5 participants did not 
have any education data. 
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Figure 1: Range of Minimum Clinically Important Differences for the Repeatable Battery for the 
Assessment of Neuropsychological Status index scores and total scale scores from distributional and 
anchor-based estimations for equivalent language indexes. 
Note:  MCID: minimum clinically important difference; CDR: clinical dementia rating scale; CAD: 
clinical assessment of dementia; SEM: standard error of measurement; SD: standard deviation. 
 
Figure 2: Range of Minimum Clinically Important Differences for the Repeatable Battery for the 
Assessment of Neuropsychological Status index scores and total scale scores from distributional and 
anchor-based estimations for visuospatial/constructional index.   
Note:  MCID: minimum clinically important difference; CDR: clinical dementia rating scale; CAD: 
clinical assessment of dementia; SEM: standard error of measurement; SD: standard deviation. 
 
Figure 3: Range of Minimum Clinically Important Differences for the Repeatable Battery for the 
Assessment of Neuropsychological Status index scores and total scale scores from distributional and 
anchor-based estimations for attention index.   
Note:  MCID: minimum clinically important difference; CDR: clinical dementia rating scale; CAD: 
clinical assessment of dementia; SEM: standard error of measurement; SD: standard deviation. 
 
 
